₹10

▼ -0.5 -4.76%

As of 27 Jul 2026 · delayed

NSE Listed

Mono Pharmacare Limited (MONOPHARMA)

Volume: 0Avg Vol 1W: 800Avg Vol 1M: 1,90052W Range:₹9.45₹27.5

NSE BSE www.monopharmacareltd.com AI Report

Key Ratios

Checked 2d ago

Market Cap₹72 Cr

Current Price₹10

Previous Close₹10.5

High / Low (52w)₹27.5 / ₹9.45

Volume0

Avg Vol (1W)800

Avg Vol (1M)1,900

Stock P/E6

Book Value₹17.66

Dividend Yield—

ROE—

ROA—

Revenue (TTM)₹169 Cr

Revenue Growth37.6%

Profit Margin—

Total Debt₹26 Cr

Shares Outstanding—

Face Value—

EPS (TTM)₹1.75

P/B0.59

Debt / Equity—

50 DMA₹11.18

200 DMA₹16.66

Day change-4.76%

Price Chart

₹10▼ 56.71% · 1Y

2025-07-30

2026-07-27

20-day avg volume: 2K shares

Pros

Stock trades below its book value.

Cons

Revenue fell 73% YoY.

Profit & Loss (Annual)

Metric	Mar 2023	Mar 2024	Mar 2025
Revenue	₹33 Cr	₹122 Cr	₹169 Cr
EBITDA	₹2 Cr	₹6 Cr	₹8 Cr
Net Profit	₹1 Cr	₹2 Cr	₹3 Cr
EPS	0.79	1.58	1.75

Balance Sheet

Metric	Mar 2023	Mar 2024	Mar 2025
Total Assets	₹63 Cr	₹81 Cr	₹110 Cr
Total Liabilities	₹49 Cr	₹53 Cr	₹79 Cr
Equity	₹14 Cr	₹28 Cr	₹31 Cr
Total Debt	—	—	—

Cash Flow

Metric	Mar 2023	Mar 2024	Mar 2025
Operating	₹-40 Cr	₹-8 Cr	₹-3 Cr
Investing	₹-1 Cr	₹0 Cr	₹0 Cr
Financing	₹41 Cr	₹8 Cr	₹5 Cr
Free Cash Flow	₹-40 Cr	₹-8 Cr	₹-3 Cr

Shareholding

Promoter 56.72% Institutions 0% Public 43.28%

Efficiency & Working Capital

ROCE10.4%

Interest Coverage2.1

Dividend Payout—

Debtor Days91 d

Inventory Days120 d

Payable Days41 d

Cash Conversion Cycle170 d

Working Capital Days211 d

Shareholding Details

As of 2026-03-31

Promoter56.7%

FII0%

DII0%

Institutions0%

Public43.3%

Promoter Pledge0%

No. of Shareholders529

Shareholding Pattern

Quarterly — figures in %. Latest 11 quarters.

Period	Apr 2023	Apr 2023	Aug 2023	Aug 2023	Sept 2023	Dec 2023	Mar 2024	Sept 2024	Mar 2025	Sept 2025	Mar 2026
Promoters	81%	81%	81%	81%	56.7%	56.7%	56.7%	56.7%	56.7%	56.7%	56.7%
FIIs	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
DIIs	19%	0%	19%	0%	0%	0%	0%	0%	0%	0%	0%
Public	0%	19%	0%	19%	43.3%	43.3%	43.3%	43.3%	43.3%	43.3%	43.3%
Promoter Pledge	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
No. of Shareholders	17	17	17	17	621	528	418	463	478	514	529

Returns History (ROE / ROCE / ROA)

Period	ROE	ROCE	ROA	P/E
202503	—	—	—	—

Major Shareholders (>1%)

Name	Category	Stake	Shares
Lakhatariya Panilam	Shareholding of Promoter and Promoter Group	45.4%	80,26,761
Supal Panilam Lakhatariya	Shareholding of Promoter and Promoter Group	11.3%	19,93,458
Shardaben Shivalal Lakhtaria	Shareholding of Promoter and Promoter Group	0%	530
Archit Shah	Shareholding of Promoter and Promoter Group	0%	530
Pallaviben Suhasbhai Shah	Shareholding of Promoter and Promoter Group	0%	530
Shivlal Gandabhai Lakhtaria	Shareholding of Promoter and Promoter Group	0%	530

Board of Directors

Name	Designation	Year
Panilam Lakhatariya	Chairman / Executive Director / M D / Promoter	2025
Supal Lakhatariya	Executive Director	2025
Archit Shah	Executive Director	2025
Chintan Trivedi	Independent Non Exe. Director	2025
Jitendra Mansukhlal Dasani	Independent Director	2025
DRASHTI ROHIT CHANDE	Independent Director	2025
Rahul Joshi	Company Sec. & Compli. Officer	2025

Segments — Product

Segment	Revenue	Share
Pharmaceutical items	₹0 Cr	—

Segments — Geography

Region	Revenue	Share
India	₹83 Cr	100%

Capital Structure (₹ Cr)

Year	Face Value	Authorised	Issued	Paid-up
2025	₹10	20	18	18

Corporate Actions

Type	Date	Value	Remark
forthcoming	2026-07-16	Board Meetings	—
forthcoming	2026-07-09	Board Meetings	—

Related-Party Transactions (₹ Cr)

Year	Subsidiaries	KMP	Others	Total
2024	83	4	75	163
2024	0	4	0	4
2024	48	1	36	84

More stocks

Meghmani Organics Limited Mold-Tek Technologies Ltd.Mold-Tek Packaging Ltd.Monarch Networth Capital Ltd.Moneyboxx Finance Limited Monolithisch India Ltd.Monte Carlo Fashions Ltd.Morarjee Textiles Limited Morepen Laboratories Ltd.Mos Utility Limited Moschip Technologies Ltd.Samvardhana Motherson International Ltd.All “M” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search